Integrated bioinformatics analysis to develop diagnostic models for malignant transformation of chronic proliferative diseases

The combined analysis of dual diseases can provide new insights into pathogenic mechanisms, identify novel biomarkers, and develop targeted therapeutic strategies. Polycythemia vera (PV) is a chronic myeloproliferative neoplasm associated with a risk of acute myeloid leukemia (AML) transformation. H...

Full description

Saved in:
Bibliographic Details
Main Authors: Hua Liu, Sheng Lin, Pei-Xuan Chen, Juan Min, Xia-Yang Liu, Ting Guan, Chao-Ying Yang, Xiao-Juan Xiao, De-Hui Xiong, Sheng-Jie Sun, Ling Nie, Han Gong, Xu-Sheng Wu, Xiao-Feng He, Jing Liu
Format: Article
Language:English
Published: Wolters Kluwer Health 2025-06-01
Series:Blood Science
Online Access:http://journals.lww.com/10.1097/BS9.0000000000000226
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849310757374656512
author Hua Liu
Sheng Lin
Pei-Xuan Chen
Juan Min
Xia-Yang Liu
Ting Guan
Chao-Ying Yang
Xiao-Juan Xiao
De-Hui Xiong
Sheng-Jie Sun
Ling Nie
Han Gong
Xu-Sheng Wu
Xiao-Feng He
Jing Liu
author_facet Hua Liu
Sheng Lin
Pei-Xuan Chen
Juan Min
Xia-Yang Liu
Ting Guan
Chao-Ying Yang
Xiao-Juan Xiao
De-Hui Xiong
Sheng-Jie Sun
Ling Nie
Han Gong
Xu-Sheng Wu
Xiao-Feng He
Jing Liu
author_sort Hua Liu
collection DOAJ
description The combined analysis of dual diseases can provide new insights into pathogenic mechanisms, identify novel biomarkers, and develop targeted therapeutic strategies. Polycythemia vera (PV) is a chronic myeloproliferative neoplasm associated with a risk of acute myeloid leukemia (AML) transformation. However, the chronic nature of disease transformation complicates longitudinal high-throughput sequencing studies of patients with PV before and after AML transformation. This study aimed to develop a diagnostic model for malignant transformation of chronic proliferative diseases, addressing the challenges of early detection and intervention. Integrated public datasets of PV and AML were analyzed to identify differentially expressed genes (DEGs) and construct a weighted correlation network. Machine-learning algorithms screen genes for potential biomarkers, leading to the development of diagnostic models. Clinical specimens were collected to validate gene expression. cMAP and molecular docking predicted potential drugs. In vitro experiments were performed to assess drug efficacy in PV and AML cells. CIBERSORT and single-cell RNA-sequencing (scRNA-seq) analyses were used to explore the impact of hub genes on the tumor microenvironment. We identified 24 genes shared between PV and AML, which were enriched in immune-related pathways. Lactoferrin (LTF) and G protein-coupled receptor 65 (GPR65) were integrated into a nomogram with a robust predictive power. The predicted drug vemurafenib inhibited proliferation and increased apoptosis in PV and AML cells. TME analysis has linked these biomarkers to macrophages. Clinical samples were used to confirm LTF and GPR65 expression levels. We identified shared genes between PV and AML and developed a diagnostic nomogram that offers a novel avenue for the diagnosis and clinical management of AML-related PV.
format Article
id doaj-art-c9812f46fbce4e428174f63738ff0cec
institution Kabale University
issn 2543-6368
language English
publishDate 2025-06-01
publisher Wolters Kluwer Health
record_format Article
series Blood Science
spelling doaj-art-c9812f46fbce4e428174f63738ff0cec2025-08-20T03:53:38ZengWolters Kluwer HealthBlood Science2543-63682025-06-0172e0022610.1097/BS9.0000000000000226202506000-00011Integrated bioinformatics analysis to develop diagnostic models for malignant transformation of chronic proliferative diseasesHua Liu0Sheng Lin1Pei-Xuan Chen2Juan Min3Xia-Yang Liu4Ting Guan5Chao-Ying Yang6Xiao-Juan Xiao7De-Hui Xiong8Sheng-Jie Sun9Ling Nie10Han Gong11Xu-Sheng Wu12Xiao-Feng He13Jing Liu14a Shenzhen Health Development Research and Data Management Center, Shenzhen 518028, Chinaa Shenzhen Health Development Research and Data Management Center, Shenzhen 518028, Chinaa Shenzhen Health Development Research and Data Management Center, Shenzhen 518028, Chinaa Shenzhen Health Development Research and Data Management Center, Shenzhen 518028, Chinaa Shenzhen Health Development Research and Data Management Center, Shenzhen 518028, Chinaa Shenzhen Health Development Research and Data Management Center, Shenzhen 518028, Chinaa Shenzhen Health Development Research and Data Management Center, Shenzhen 518028, Chinaa Shenzhen Health Development Research and Data Management Center, Shenzhen 518028, Chinaa Shenzhen Health Development Research and Data Management Center, Shenzhen 518028, Chinaa Shenzhen Health Development Research and Data Management Center, Shenzhen 518028, Chinac Department of Hematology, Xiangya Hospital, Central South University, Changsha 410078, Chinaa Shenzhen Health Development Research and Data Management Center, Shenzhen 518028, Chinaa Shenzhen Health Development Research and Data Management Center, Shenzhen 518028, Chinaa Shenzhen Health Development Research and Data Management Center, Shenzhen 518028, Chinaa Shenzhen Health Development Research and Data Management Center, Shenzhen 518028, ChinaThe combined analysis of dual diseases can provide new insights into pathogenic mechanisms, identify novel biomarkers, and develop targeted therapeutic strategies. Polycythemia vera (PV) is a chronic myeloproliferative neoplasm associated with a risk of acute myeloid leukemia (AML) transformation. However, the chronic nature of disease transformation complicates longitudinal high-throughput sequencing studies of patients with PV before and after AML transformation. This study aimed to develop a diagnostic model for malignant transformation of chronic proliferative diseases, addressing the challenges of early detection and intervention. Integrated public datasets of PV and AML were analyzed to identify differentially expressed genes (DEGs) and construct a weighted correlation network. Machine-learning algorithms screen genes for potential biomarkers, leading to the development of diagnostic models. Clinical specimens were collected to validate gene expression. cMAP and molecular docking predicted potential drugs. In vitro experiments were performed to assess drug efficacy in PV and AML cells. CIBERSORT and single-cell RNA-sequencing (scRNA-seq) analyses were used to explore the impact of hub genes on the tumor microenvironment. We identified 24 genes shared between PV and AML, which were enriched in immune-related pathways. Lactoferrin (LTF) and G protein-coupled receptor 65 (GPR65) were integrated into a nomogram with a robust predictive power. The predicted drug vemurafenib inhibited proliferation and increased apoptosis in PV and AML cells. TME analysis has linked these biomarkers to macrophages. Clinical samples were used to confirm LTF and GPR65 expression levels. We identified shared genes between PV and AML and developed a diagnostic nomogram that offers a novel avenue for the diagnosis and clinical management of AML-related PV.http://journals.lww.com/10.1097/BS9.0000000000000226
spellingShingle Hua Liu
Sheng Lin
Pei-Xuan Chen
Juan Min
Xia-Yang Liu
Ting Guan
Chao-Ying Yang
Xiao-Juan Xiao
De-Hui Xiong
Sheng-Jie Sun
Ling Nie
Han Gong
Xu-Sheng Wu
Xiao-Feng He
Jing Liu
Integrated bioinformatics analysis to develop diagnostic models for malignant transformation of chronic proliferative diseases
Blood Science
title Integrated bioinformatics analysis to develop diagnostic models for malignant transformation of chronic proliferative diseases
title_full Integrated bioinformatics analysis to develop diagnostic models for malignant transformation of chronic proliferative diseases
title_fullStr Integrated bioinformatics analysis to develop diagnostic models for malignant transformation of chronic proliferative diseases
title_full_unstemmed Integrated bioinformatics analysis to develop diagnostic models for malignant transformation of chronic proliferative diseases
title_short Integrated bioinformatics analysis to develop diagnostic models for malignant transformation of chronic proliferative diseases
title_sort integrated bioinformatics analysis to develop diagnostic models for malignant transformation of chronic proliferative diseases
url http://journals.lww.com/10.1097/BS9.0000000000000226
work_keys_str_mv AT hualiu integratedbioinformaticsanalysistodevelopdiagnosticmodelsformalignanttransformationofchronicproliferativediseases
AT shenglin integratedbioinformaticsanalysistodevelopdiagnosticmodelsformalignanttransformationofchronicproliferativediseases
AT peixuanchen integratedbioinformaticsanalysistodevelopdiagnosticmodelsformalignanttransformationofchronicproliferativediseases
AT juanmin integratedbioinformaticsanalysistodevelopdiagnosticmodelsformalignanttransformationofchronicproliferativediseases
AT xiayangliu integratedbioinformaticsanalysistodevelopdiagnosticmodelsformalignanttransformationofchronicproliferativediseases
AT tingguan integratedbioinformaticsanalysistodevelopdiagnosticmodelsformalignanttransformationofchronicproliferativediseases
AT chaoyingyang integratedbioinformaticsanalysistodevelopdiagnosticmodelsformalignanttransformationofchronicproliferativediseases
AT xiaojuanxiao integratedbioinformaticsanalysistodevelopdiagnosticmodelsformalignanttransformationofchronicproliferativediseases
AT dehuixiong integratedbioinformaticsanalysistodevelopdiagnosticmodelsformalignanttransformationofchronicproliferativediseases
AT shengjiesun integratedbioinformaticsanalysistodevelopdiagnosticmodelsformalignanttransformationofchronicproliferativediseases
AT lingnie integratedbioinformaticsanalysistodevelopdiagnosticmodelsformalignanttransformationofchronicproliferativediseases
AT hangong integratedbioinformaticsanalysistodevelopdiagnosticmodelsformalignanttransformationofchronicproliferativediseases
AT xushengwu integratedbioinformaticsanalysistodevelopdiagnosticmodelsformalignanttransformationofchronicproliferativediseases
AT xiaofenghe integratedbioinformaticsanalysistodevelopdiagnosticmodelsformalignanttransformationofchronicproliferativediseases
AT jingliu integratedbioinformaticsanalysistodevelopdiagnosticmodelsformalignanttransformationofchronicproliferativediseases